Sarcopenia and menopause

Affiliations

Editorial

James H Liu. Menopause. 2023.

. 2023 Feb 1;30(2):119-120.

doi: 10.1097/GME.0000000000002140. Epub 2022 Dec 28.

No abstract available

Conflict of interest statement

Financial disclosure/conflicts of interest: J.H.L. receives funding from Bayer Healthcare and Aveta.

Loss of muscle mass in women with premature ovarian insufficiency as compared with healthy controls.
Li S, Ma L, Huang H, Lou Z, Qi T, Huang Y, Zou Y, Zhou J. Li S, et al. Menopause. 2023 Feb 1;30(2):122-127. doi: 10.1097/GME.0000000000002120. Epub 2022 Nov 20. Menopause. 2023. PMID: 36696635

1. Maltais ML, Desroches H, Dionne IJ. Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact 2009;9:186–197. PMID 19949277
1. Lang T, Streeper T, Cawthon P, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010;21:543–559. doi: 10.1007/s00198-009-1059-y - DOI
1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2018;48:16–31. doi: 10.1093/ageing/afy169 - DOI
1. Chen L-K, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020;21:300–307.e2. doi: 10.1016/j.jamda.2019.12.012 - DOI
1. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia; joint document elaborated by Special Interest Group (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010;29:154–159. doi: 10.1016/j.clnu.2009.12.004 - DOI